<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="correction">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Lancet</journal-id>
      <journal-id journal-id-type="iso-abbrev">Lancet</journal-id>
      <journal-title-group>
        <journal-title>Lancet</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0140-6736</issn>
      <issn pub-type="epub">1474-547X</issn>
      <publisher>
        <publisher-name>Lancet Publishing Group</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">22920751</article-id>
      <article-id pub-id-type="pmc">3491842</article-id>
      <article-id pub-id-type="publisher-id">LANCET61408</article-id>
      <article-id pub-id-type="doi">10.1016/S0140-6736(12)61408-1</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Department of Error</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Department of Error</article-title>
      </title-group>
      <pub-date pub-type="pmc-release">
        <day>25</day>
        <month>8</month>
        <year>2012</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="ppub"/>. -->
      <pub-date pub-type="ppub">
        <day>25</day>
        <month>8</month>
        <year>2012</year>
      </pub-date>
      <volume>380</volume>
      <issue>9843</issue>
      <fpage>730</fpage>
      <lpage>730</lpage>
      <permissions>
        <copyright-statement>&#xA9; 2012 Elsevier Ltd. All rights reserved.</copyright-statement>
        <copyright-year>2012</copyright-year>
        <copyright-holder>Elsevier Ltd</copyright-holder>
        <license>
          <license-p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</license-p>
        </license>
      </permissions>
      <related-article related-article-type="corrected-article" id="d31e11" ext-link-type="doi" xlink:href="10.1016/S0140-6736(12)60768-5"/>
    </article-meta>
  </front>
  <body>
    <p><italic>The IST-3 collaborative group. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.</italic> Lancet <italic>2012;</italic>
<bold><italic>379:</italic></bold>
<italic>2352-63</italic>&#x2014;In this Article (June 23), the affiliations for two members of the writing committee were incorrect. Anna Czlonkowska's affiliations should have been &#x201C;Institute of Psychiatry and Neurology, Warsaw, Poland, and Medical University of Warsaw, Warsaw, Poland&#x201D;. Adam Kobayashi's affiliation should have been &#x201C;Institute of Psychiatry and Neurology, Warsaw, Poland&#x201D;. These corrections have been made to the online version as of Aug 24, 2012.</p>
  </body>
</article>
</pmc-articleset>
